Published in Transplant Rev on January 01, 1975
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11
Systemic tolerance and secretory immunity after oral immunization. J Exp Med (1980) 3.79
Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med (1983) 3.52
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med (1979) 2.09
Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line. J Exp Med (1978) 2.01
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations. J Exp Med (1977) 1.70
Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J Exp Med (1980) 1.54
Dengue virus-induced thymus-derived suppressor cells in the spleen of mice. Immunology (1979) 1.50
Studies on delayed hypersensitivity in mice. III. Evidence for suppressive regulatory T1-cell population in delayed hypersensitivity. J Exp Med (1977) 1.31
Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29
Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clin Exp Immunol (1977) 1.19
Tolerance induction during ontogeny. I. Presence of active suppression in mice rendered tolerant to human gamma-globulin in utero correlates with the breakdown of the tolerant state. J Exp Med (1979) 1.18
Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14
Thymus-dependent lymphocytes of dengue virus-infected mice spleens mediate suppression through prostaglandin. Immunology (1981) 1.10
Distinction between suppressors of the delayed-type hypersensitivity and the humoral response to sheep erythrocytes. Immunology (1978) 1.09
Antigen-laden cells in thoracic duct lymph. Implications for adoptive transfer experiments. Immunology (1979) 1.09
Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice. Immunology (1987) 1.07
Antigen mediation of a late-acting suppressor T-cell activity. J Exp Med (1977) 0.97
A regulatory role for the memory B cell as suppressor-inducer of feedback control. J Exp Med (1983) 0.97
Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine. J Exp Med (1979) 0.94
Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory. J Exp Med (1982) 0.94
Anti-erythrocyte autoantibody production in mice associated with the injection of rat erythrocytes. Immunology (1980) 0.92
Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine. Infect Immun (1979) 0.91
Effect of colchicine on the antibody response. II. Demonstration of the inactivation of suppressor cell activities by colchicine. J Exp Med (1978) 0.88
Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor. J Exp Med (1980) 0.87
Memory cell generation ablated by soluble protein antigen by means of effects on T- and B-lymphocyte compartments. Proc Natl Acad Sci U S A (1992) 0.86
Direct visualization of T lymphocytes bearing Ia antigens controlled by the I-J subregion. J Exp Med (1977) 0.85
Feedback control of the secondary antibody response. I. A suppressor, suppressor-inducer mechanism from the interaction of B-memory cells with Lyt 2- T cells. Immunology (1983) 0.84
Enhanced antibody affinity in sublethally irradiated mice and bone marrow chimeras. Proc Natl Acad Sci U S A (1977) 0.82
Characterization of the human peripheral effector cells mediating antibody dependent cellular cytotoxicity against allogenic cells. Clin Exp Immunol (1979) 0.81
A suppressor mechanism controlling lymphocyte recruitment. Immunology (1977) 0.81
Cellular basis of persistent tolerance induced by an aggregate free heterologous immunoglobulin. Immunology (1977) 0.81
Incidental appearance of suppressor T cells in the induction of immunological tolerance. Immunology (1978) 0.78
Immunoglobulin production in the autologous MLR: target of the suppressor-amplifier circuit. Clin Exp Immunol (1986) 0.78
Special regulatory T-cell review: T-cell dependent suppression revisited. Immunology (2008) 0.77
The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease. Clin Exp Immunol (1977) 0.77
In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas. Br J Cancer (1985) 0.76
Effects of whole-body irradiation on antibody affinity. Immunology (1977) 0.75
The effect of neonatal tolerance to bovine gamma globulin (BGG) on BGG-reactive CD4+ T lymphocytes. Immunology (1992) 0.75
Local passive transfer of delayed type hypersensitivity to syngeneic testicular cells in mice. Clin Exp Immunol (1984) 0.75
Differential major histocompatibility complex-related activation of idiotypic suppressor T cells. Suppressor T cells cross-reactive to two distantly related lysozymes are not induced by one of them. J Exp Med (1980) 0.75
High-density proteoglycan induces specific suppression of adjuvant-induced arthritis in rats. Clin Exp Immunol (1994) 0.75
Enhancing and inhibiting effects of spleen cells from tumour-bearing mice on growth of virus-induced primary sarcoma. Br J Cancer (1978) 0.75
Regulation of macrophage phagocytosis of syngeneic erythrocytes by T-cell subsets from NZB mice: differential effects of T cells from young and old mice. Immunology (1982) 0.75
Studies on the control of antibody synthesis. XVII. Effect of specific suppressor cells on the affinity of the antibody response by naive or primed lymphocytes. Immunology (1980) 0.75
High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 34.78
Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med (1968) 12.91
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med (1968) 9.67
Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84
An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (1996) 8.81
Current concepts of the immunological function of the thymus. Physiol Rev (1967) 8.37
Immunological activity of thymus and thoracic-duct lymphocytes. Proc Natl Acad Sci U S A (1968) 7.49
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med (1999) 7.28
The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect (2008) 5.98
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MAT alpha 2 repressor. Cell (1993) 5.05
Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med (1968) 5.02
The Asgaard project: a task-specific framework for the application and critiquing of time-oriented clinical guidelines. Artif Intell Med (1998) 4.87
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Isolation, experimental transmission, and characterization of causative agent of Potomac horse fever. Science (1985) 4.12
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
The thymus and the precursors of antigen reactive cells. Nature (1967) 3.92
Role of major histocompatibility complex gene products in delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1976) 3.69
Cellular basis of the immunological defects in thymectomized mice. Nature (1967) 3.69
Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell (1995) 3.64
XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res (1996) 3.51
Equity in the finance of health care: some further international comparisons. J Health Econ (1999) 3.48
BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun (1994) 3.44
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
H-2 gene complex restricts transfer of delayed-type hypersensitivity in mice. Proc Natl Acad Sci U S A (1975) 3.34
Do Apgar scores indicate asphyxia? Lancet (1982) 3.32
Regeneration of thymus grafts. I. Histological and cytological aspects. Transplantation (1965) 3.29
Roles for motility in bacterial-host interactions. Mol Microbiol (1997) 3.16
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci U S A (1989) 2.99
The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect (2010) 2.95
Early embryonic mortality in women. Fertil Steril (1982) 2.92
A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (1998) 2.85
Nucleotide sequence changes produced by mutations in the lac promoter of Escherichia coli. J Mol Biol (1977) 2.84
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood (1998) 2.83
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Fetal loss after implantation. A prospective study. Lancet (1980) 2.73
Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.71
Treatment of hypertension with methyldopa. Br Med J (1966) 2.69
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A (1992) 2.67
Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A (1995) 2.66
A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64
Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell (1998) 2.59
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol (1975) 2.48
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature (2001) 2.47
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J (1996) 2.41
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Acid-base status at birth and neurodevelopmental outcome at four and one-half years. Am J Obstet Gynecol (1989) 2.38
Prolonged expiratory apnoea: a disorder resulting in episodes of severe arterial hypoxaemia in infants and young children. Lancet (1985) 2.36
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
A three-year follow up of tension free vaginal tape for surgical treatment of female stress urinary incontinence. Br J Obstet Gynaecol (1999) 2.30
The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes. J Bacteriol (1989) 2.29
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med (1997) 2.27
Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26
The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med (1998) 2.25
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Growth of B lymphocyte colonies in vitro from mouse lymphoid organs. Nature (1975) 2.24
Tolerance of class I histocompatibility antigens expressed extrathymically. Nature (1989) 2.19
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc Natl Acad Sci U S A (1989) 2.15
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer (2009) 2.13
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
Marked hypocalcemia and ventricular fibrillation in two pediatric patients exposed to a fluoride-containing wheel cleaner. Ann Emerg Med (1996) 2.11
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol (1971) 2.07
Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum (1988) 2.06
Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry (1997) 2.04
Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology. Gut (1991) 2.04
A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol (1997) 2.01
Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line. J Exp Med (1978) 2.01
The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol (1998) 1.99
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol (1993) 1.94